Atlas Trials

Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma

Clinical trial NCT05854030 · UNKNOWN

Trial details

NCT number
NCT05854030
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung NeoplasmSquamous Cell CarcinomaExosomes
Start date
2022-04-01
Primary completion
2023-07-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.